Organic Tea Cosmetics Holdings Valuation

Is A900300 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A900300 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A900300 (₩680) is trading below our estimate of fair value (₩1507.4)

Significantly Below Fair Value: A900300 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A900300?

Key metric: As A900300 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A900300. This is calculated by dividing A900300's market cap by their current revenue.
What is A900300's PS Ratio?
PS Ratio	0.2x
Sales	₩164.81b
Market Cap	₩33.19b

A900300 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does A900300's PS Ratio compare to its peers?

The above table shows the PS ratio for A900300 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
A318010 Pharmsville	1.9x	n/a	₩33.4b
A317240 TS Trillion	0.8x	n/a	₩29.8b
A900120 CXI Healthcare Technology Group	0.3x	n/a	₩21.9b
A227610 Outin Futures	1.4x	n/a	₩47.4b
A900300 Organic Tea Cosmetics Holdings	0.2x	n/a	₩33.2b

Price-To-Sales vs Peers: A900300 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.1x).

Price to Sales Ratio vs Industry

How does A900300's PS Ratio compare vs other companies in the KR Personal Products Industry?

1 Company	Price / Sales	Estimated Growth	Market Cap
A044820 Cosmax BTI	0.1x	n/a	US$57.76m

No more companies available in this PS range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: A900300 is good value based on its Price-To-Sales Ratio (0.2x) compared to the KR Personal Products industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is A900300's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A900300 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A900300's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeoPharm

₩181.1b

Engages in the manufacturing and sale of skin care products in South Korea.

A092730

₩11,580.00

-11.4%

2.7%

NOVAREXLtd

₩135.1b

Manufactures, wholesales, and retails health and functional foods in South Korea and internationally.

A194700

₩7,630.00

-4.9%

-30.8%

₩1.0t

Produces and exports laminating machines and films worldwide.

A018290

₩28,900.00

-6.6%

61.2%